J Pain Symptom Manage
Dr. Rachel E. Rosenblum, MD
- Medicare services, 2024
- 1,106
- Medicare patients, 2024
- 283
- Part D claims, 2024
- 770
- Publications
- 4
- MIPS score, 2024
- 83
- Practice address
- 1275 York Avenue, New York, NY 10065
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Rosenblum's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Rachel E. Rosenblum is a hematologist and oncologist in New York, New York
Dr. Rosenblum practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.
Dr. Rosenblum's NPI, 1184087249, was assigned on April 5, 2016. Dr. Rosenblum holds New Jersey license 25MA11948400.
- NPI
- 1184087249NPI Registry (opens in a new tab)
- Medicare PAC ID
- 2668718719
- NPI enumeration date
- April 5, 2016
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 36
- Medical school graduation
- 2016
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Rachel E. Rosenblum practices at Memorial Sloan Kettering Cancer Center in New York, New York
Dr. Rosenblum's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.
- Memorial Sloan Kettering Cancer Center1275 York Avenue, New York, NY 10065
Source: Dmand AI Affiliation Data
Dr. Rachel E. Rosenblum is affiliated with 5 sites of care and 2 medical groups
Dr. Rosenblum's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. Dr. Rosenblum is also affiliated with Riverview Medical Center. The medical group on file is Memorial Sloan Kettering Cancer Center. Dmand AI also links Dr. Rosenblum to 2 more group practices and clinics, 1 home health agency and 1 medical group, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Rachel E. Rosenblum's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rosenblum practices, 5 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Memorial Sloan Kettering Cancer Center | Available with a free account |
| +4 more sites and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Memorial Sloan Kettering Cancer Center and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Rachel E. Rosenblum is one of 996 hematologists and oncologists in New York
Hematology and oncology is Dr. Rosenblum's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Rosenblum's licenses on file in 2 states: New Jersey and Pennsylvania.
Specialties and state licenses
- Hematology and oncology, New JerseyPrimary
- Pennsylvania license
Hematologists and oncologists near Dr. Rosenblum
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Rachel E. Rosenblum billed Medicare for 1,106 services in 2024
CMS data shows 1,106 Medicare services from Dr. Rosenblum across 7 procedure codes in 2024, for 283 Medicare patients. Medicare paid $98,752 for them. Every service was in an office.
Dr. Rosenblum's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 2492024: 1,079333%
- Other services
- 2023: 02024: 27
Dr. Rosenblum compared with the New York median for hematologists and oncologists, 2024
- Dr. Rosenblum
- New York median
- Medicare services
- 1,106vs 66866% above
- Medicare patients
- 283vs 21035% above
- Part D claims
- 561vs 2582.2 times
Medians across 940 hematologists and oncologists in New York with Dmand AI profiles that report each measure.
Dr. Rosenblum's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Rosenblum?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Rosenblum and other hematologists and oncologists in New York.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Rachel E. Rosenblum treated 283 Medicare patients in 2024, average age 75
CMS counts 283 Medicare patients who saw Dr. Rosenblum in 2024. The largest group is 65 to 74, with 128 patients. 75% of them have cancer, and 75% have high blood pressure. 6% are also on Medicaid. Their average risk score is 2.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Rosenblum's median patient age at 75, with 60% women.
Dr. Rosenblum's Medicare patients by age, 2024
Dr. Rosenblum's Medicare patients by sex, 2024
- Women16960%
- Men11440%
Chronic conditions among Dr. Rosenblum's Medicare patients, 2024
- Cancer75%
- High blood pressure75%
- High cholesterol75%
- COPD61%
- Arthritis52%
- Ischemic heart disease43%
- Anxiety42%
- Diabetes38%
Share of Medicare patients with each condition. A patient can have several.
Dr. Rosenblum's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 75
Patient panel by sex, all payers
- Women60%
- Men39%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Rachel E. Rosenblum wrote 770 Medicare Part D claims in 2024
In 2024, Dr. Rosenblum wrote 770 Medicare Part D claims for 168 patients. 65% of them were for generic drugs. CMS names the drug for 561 of them, across 15 drugs with 11 or more claims each, at $2,184,103 in total drug cost. In 2023, CMS named 64 claims across 4 drugs.
Dr. Rosenblum's Part D claims by kind of drug, 2024
- Generic503 claims65%
- Brand-name and other267 claims35%
Dr. Rosenblum's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Rosenblum's Part D claims, 2024
- Opioids3%23 of 770 claims
- Antibiotics3%25 of 770 claims
- Antipsychotics, patients 65 and over1%11 of 770 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 642024: 561777%
Drugs named by CMS: 15 in 2024, 4 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Rachel E. Rosenblum scored 83 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Rosenblum for performance year 2024, reported as part of a group. Dr. Rosenblum accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rosenblum as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Rosenblum's MIPS scores, performance year 2024
- 83of 100Final score
- 80.9of 100Quality
- 40of 100Improvement Activities
- 65of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Rachel E. Rosenblum has 4 publications on record
Dmand AI links 4 papers to Dr. Rosenblum, published from 2020 to 2022. 2022 was the busiest year, with 2. The most frequent topics are Palliative Care. Dr. Rosenblum's most frequent co-authors are Mamta Bhatnagar, Jennifer Ang Chan, MD and Thomas Edward Clancy, MD.
Topics Dr. Rosenblum writes about most
- Palliative Care
Dr. Rosenblum's most frequent co-authors
- Mamta Bhatnagar1 shared paper
- Jennifer Ang Chan, MD1 shared paper
- Thomas Edward Clancy, MD1 shared paper
Recent publications by Dr. Rosenblum
See who Dr. Rosenblum researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Rosenblum works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Rachel E. Rosenblum received $6,831 in industry payments from 2019 to 2023
CMS Open Payments shows 13 general payments to Dr. Rosenblum from 6 drug and device companies from 2019 to 2023. Consulting fees make up the largest share, 81% of the total. Bristol-Myers Squibb Company paid the most, $4,447.
General payments to Dr. Rosenblum by program year, 2019 to 2023
General payments to Dr. Rosenblum by kind, 2019 to 2023
- Consulting fees$5,50081%
- Travel and lodging$75811%
- Food and beverage$5748%
Companies that paid Dr. Rosenblum the most, 2019 to 2023
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Rachel E. Rosenblum's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Rachel E. Rosenblum
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Rachel E. Rosenblum's NPI number?
Dr. Rachel E. Rosenblum's NPI number is 1184087249. It was assigned on April 5, 2016, and it is active in the NPI Registry.
What kind of doctor is Dr. Rachel E. Rosenblum?
Dr. Rachel E. Rosenblum is a hematologist and oncologist in New York, New York. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Rachel E. Rosenblum practice?
Dr. Rosenblum practices at 1275 York Avenue, New York, NY 10065. Dr. Rosenblum's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. Dmand AI also links Dr. Rosenblum to 2 group practices and clinics, 1 home health agency and 1 medical group.
What is Dr. Rachel E. Rosenblum's medical license number?
Dr. Rosenblum holds New Jersey license 25MA11948400, one of the licenses on file in 2 states.
Which states has Dr. Rachel E. Rosenblum been licensed in?
Dmand AI has state licenses on file for Dr. Rosenblum in New Jersey and Pennsylvania.
Which hospitals is Dr. Rachel E. Rosenblum affiliated with?
Dr. Rosenblum practices at Memorial Sloan Kettering Cancer Center in New York, New York. Dr. Rosenblum is also affiliated with Riverview Medical Center.
What medical group is Dr. Rachel E. Rosenblum part of?
Dr. Rosenblum is linked to Memorial Sloan Kettering Cancer Center. Dmand AI links Dr. Rosenblum to 1 more medical group.
Does Dr. Rachel E. Rosenblum accept Medicare?
Yes. CMS data shows Dr. Rosenblum billed Medicare for 1,106 services in 2024, and Dr. Rosenblum accepts Medicare assignment.
Does Dr. Rachel E. Rosenblum offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Rosenblum as offering telehealth services.
What is Dr. Rachel E. Rosenblum's MIPS score?
Dr. Rosenblum's MIPS final score for performance year 2024 is 83 out of 100, reported as part of a group.
Show 7 more questionsShow fewer questions
How many Medicare patients does Dr. Rachel E. Rosenblum see?
CMS counts 283 Medicare patients who saw Dr. Rosenblum in 2024, with an average age of 75.
What services does Dr. Rachel E. Rosenblum bill to Medicare?
In 2024, Dr. Rosenblum's most billed Medicare services were office visit, established patient (99214), office visit, established patient (99215) and office visit, new patient (99205).
What drugs does Dr. Rachel E. Rosenblum prescribe most?
In 2024 Medicare Part D data, Dr. Rosenblum's most prescribed drugs by claims were Tagrisso, Dexamethasone and Prochlorperazine Maleate.
Has Dr. Rachel E. Rosenblum received payments from drug or device companies?
CMS Open Payments shows $6,831 in general payments to Dr. Rosenblum from 6 companies from 2019 to 2023. The largest total came from Bristol-Myers Squibb Company.
How long has Dr. Rachel E. Rosenblum been practicing?
Dr. Rosenblum graduated from medical school in 2016, 10 years ago.
Does Dr. Rachel E. Rosenblum do research?
Dmand AI links 4 publications to Dr. Rosenblum, published from 2020 to 2022.
Who does Dr. Rachel E. Rosenblum publish with?
Dr. Rosenblum's most frequent co-authors are Mamta Bhatnagar (1 shared paper), Jennifer Ang Chan, MD (1 shared paper) and Thomas Edward Clancy, MD (1 shared paper).
Selling to hematology and oncology practices?
See hematologists and oncologists in New York by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card